Welcome to BioMarket Group!

Analytical Tool - Apoptosis in Oncology

Additional Information

Published Date Mar 25, 2014
Pages No
License Prices No
PDF Fact Sheet No
Format PDF & Desktop App plus Online Access to Updates (One Year)
Publisher BioSeeker Group

Availability: In stock

$4,650.00

Quick Overview

In this Analytical Tool, BioSeeker Group brings light and understanding of the whole industrial endeavor in apoptosis as cancer therapeutic mechanism.
Request free sample pages from Analytical Tool - Apoptosis in Oncology

"Analytical Tool - Apoptosis in Oncology" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in apoptotic drug development for the treatment of cancer. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and their progress. This tool provides you with an immense amount of information structured and analyzed to assist you in your work. It is designed to assist you in finding right partners, optimizing your licensing deals, wisely choosing which projects give you the best competitive advantage, and assuring you that your decisions have been based on the most accurate, validated and precise facts available.

Included in this advantageous package are two products already appreciated by many of our customers:


The Package Includes

  • A progress analysis on current and emerging drugs
  • Information on most companies active in apoptotic drug R&D
  • Information on key industry related apoptotic drug projects
  • Data from most important clinical trials
  • Information on early developmental stage projects
  • Possibility of performing advanced searches suited to your individual needs

This Tool will Assist You in:

  • Tracking cutting edge companies, therapies and new technologies
  • Rapid identification of partners & competitors
  • Laying down a comprehensive framework for further analysis of the field
  • Producing presentations surrounding the development of apoptotic drugs in oncology
  • Identifying emerging apoptotic cancer products & key areas of pharmaceutical R&D

*This software application is a searchable database reflects the most recent advances in the field of apoptotic cancer drug development, in order to help you perform your own analysis, go back to the source data for in-depth information, and present the research and development in tables and graphs suited for your own specific purposes. A significant advantage with BioSeeker’s software applications is that they provide you with well-structured information. Each pipeline drug/project has been carefully defined and classified in categories and subcategories. The main categories include therapy type, effect, mechanism of action (molecular target), indication, stage of development etc. These categories are further organized and classified in sub-categories. In comparison with other available databases, BioSeeker’s software applications give better overview, specific search capabilities and great dynamic reports.



License Prices:

Request free sample pages from Analytical Tool - Apoptosis in Oncology

Other selected research from the 'Analytical Tool' category:


Analytical Tool - Antibodies in Oncology
Premium analysis tool on the commercial development of antibodies in oncology. This unique tool integrates system biology into traditional business information in order to achieve best practice when it comes to analyzing and understand targeted therapy and personalized medicine of antibodies in oncology. Learn More


Analytical Tool - Angiogenesis in Oncology
The ultimate tool for serious players who would like to understand the current competitive field in cancer drug development among anti-angiogenic and vascular targeting agents. Learn More

Other selected research from the 'R&D' category:


Analytical Tool - Breast Cancer
The ultimate tool for serious players who would like to understand the current competitive field in breast cancer drug development. Learn More


Colorectal Cancer Drug Pipeline Update
BioSeeker Group have identified 426 companies plus partners who are today developing 509 drugs targeting colorectal cancer in development. across 346 different targets. In addition, there are 6 suspended drugs and another 211 drugs where development has been ceased. Learn More

Other selected research from the 'Oncology' category:


Cellular Therapy in Oncology Drug Pipeline Update
BioSeeker Group have identified 164 companies plus partners who are today developing 272 cellular therapy drugs in 577 developmental projects in cancer across 92 different targets. In addition, there are 7 suspended drugs and another 66 drugs where development has been ceased. Learn More


IL-4 Signaling Pathway in Oncology Drug Pipeline Update
BioSeeker Group have identified 208 companies plus partners who are today developing 274 IL-4 pathway targeting drugs in 988 developmental projects in cancer across 161 different targets. In addition, there are 4 suspended drugs and another 105 drugs where development has been ceased. Learn More